Compile Data Set for Download or QSAR
Report error Found 520 Enz. Inhib. hit(s) with all data for entry = 85
TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162366(US9687479, 3 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162367(US9687479, 4 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162368(US9687479, 5 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162369(US9687479, 6 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162370(US9687479, 23 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162371(US9687479, 25 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162372(US9687479, 26 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162373(US9687479, 27 1-[(2-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162374(US9687479, 28 1-[(2-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162375(US9687479, 29 1-[(2-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162406(US9687479, 31 1-[(3-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162407(US9687479, 32 1-[(3-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162409(US9687479, 33 1-[(3-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162456(US9687479, 35 1-[(4-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162471(US9687479, 36 1-[(4-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162557(US9687479, 37 1-[(4-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162559(US9687479, 39 1-[(5-chlorothiophen-2-yl)methyl]-3-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162560(US9687479, 40 1-[(5-chlorothiophen-2-yl)methyl]-3-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162561(US9687479, 41 1-[(5-chlorothiophen-2-yl)methyl]-3-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162563(US9687479, 43 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162564(US9687479, 44 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162565(US9687479, 45 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162566(US9687479, 46 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162567(US9687479, 47 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162568(US9687479, 48 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162569(US9687479, 49 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162570(US9687479, 50 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162571(US9687479, 51 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162572(US9687479, 52 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162573(US9687479, 53 1-benzyl-3-(5-[(5-chlorothiophen-2-y...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162575(US9687479, 55 1-benzyl-3-1-[(2-chlorophenyl)carbon...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162576(US9687479, 56 2-[3-(5-[(5-chlorothiophen-2-yl)meth...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162577(US9687479, 57 2-[3-(5-[(5-chlorothiophen-2-yl)meth...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162578(US9687479, 58 2-[3-(5-[(5-chlorothiophen-2-yl)meth...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162581(US9687479, 61 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162582(US9687479, 62 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162583(US9687479, 63 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162584(US9687479, 64 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162585(US9687479, 65 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162586(US9687479, 66 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162587(US9687479, 67 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162589(US9687479, 69 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162590(US9687479, 70 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162591(US9687479, 71 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162592(US9687479, 72 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162593(US9687479, 73 3-(1-benzoyl-5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162594(US9687479, 74 3-(5-[(4-fluorophenyl)methyl]amino-1...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162595(US9687479, 75 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162596(US9687479, 76 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162597(US9687479, 77 3-(5-[(5-chlorothiophen-2-yl)methyl]...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 520 total ) | Next | Last >>
Jump to: